About Medreich Limited
Data last updated:
Medreich Limited is a public limited company based in Bangalore, Karnataka, India, a subsidiary of Meiji Seika Pharma Co., Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 August 1973 and has been in existence for over 53 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA1973PLC002383. Its GSTIN is 29AABCM1458Q1ZW (Karnataka). The company holds 6 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹160.5 Cr and a paid-up capital of ₹40.16 Cr. It was formerly known as Sterilab Private Limited and Medreich Sterilab Private Limited. It is led by directors including Pankaj Garg (Managing Director) and Tsutomu Yamada.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Medreich House No.12/8 Saraswathi Ammal Street Maruthi Seva Nagar, Bangalore, Karnataka, India – 560033.
As per the financials filed for FY 2024, the company reported a revenue of ₹1,737.11 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹226.55 Cr (net margin 13%) and EBITDA of ₹294.66 Cr (EBITDA margin 17%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 9% over five years.
The company has about 1,833 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries and 1 joint venture.
The company is associated with 1 brand: Medreich. As per MCA filings, the company has satisfied charges of ₹662.34 Cr on record. Court records list 53 cases involving the company, including 25 filed by the company and 13 filed against it; 10 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in June 2015. The company has 3 MSME Form 1 returns on record between 2019 and 2024, listing 16 overdue payments to 8 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medreich.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressMedreich House No.12/8 Saraswathi Ammal Street Maruthi Seva Nagar, Bangalore, Karnataka, India – 560033
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Medreich Limited FY 2025 filings available
Medreich Limited reported revenue of ₹1,737.11 Cr (up 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Medreich Limited
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 8% growth in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medreich Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹294.66 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹226.55 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medreich Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 13% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medreich are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Medreich Limited
Medreich Limited is audited by S.R. Batliboi & Associates LLP for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.R. Batliboi & Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medreich Limited
Medreich has 6 current directors and 42 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tsutomu Yamada | Director | 31 Jul 2023 | 3 Years 2 Months | Current |
| Pankaj Garg | Managing Director | 31 Jul 2015 | 11 Years 2 Months | Current |
| Yasuhiro Nakagiri Also directs: Adcock Ingram Limited, Adcock Ingram Pharma Private Limited | Additional Director | 09 May 2024 | 2 Years 5 Months | Current |
| Misa Hirose | Director | 28 Jun 2022 | 4 Years 3 Months | Current |
| Kenshi Murase Also directs: Adcock Ingram Limited, Adcock Ingram Pharma Private Limited | Director | 02 Jul 2018 | 8 Years 3 Months | Current |
| Ryoji Kikuchi | Director | 16 Jul 2021 | 5 Years 2 Months | Current |
Ownership and Shareholding of Medreich Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medreich Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Apr 2022 | Standard Chartered Bank | ₹1.7 Cr | Satisfied |
| 13 May 2019 | Standard Chartered Bank | ₹100 Cr | Satisfied |
| 11 Oct 2013 | Standard Chartered Bank | ₹100.8 Cr | Satisfied |
| 13 Aug 2013 | The Hongkong & Shanghai Banking Corporation Limited | ₹30 Cr | Satisfied |
| 13 Aug 2013 | The Hongkong and Shanghai Banking Corporation Limited | ₹75.6 Cr | Satisfied |
Total charge records: 11 View all charges
Deals & Funding of Medreich Limited
Medreich Limited has 1 deal on record (1 secondary share transfer); the latest was in June 2015.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2015 | Secondary share transfer | Undisclosed | Buyer: Thai Meiji Pharmaceuticals Co.., Ltd, Meiji Pharma Spain, S.a, Meiji Pharma Korea Co...Ltd, an individual Seller: Med Holdings (Uk) Limited, Nokha Trading Private Limited , 2 individuals |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Medreich Limited
Medreich Limited has 53 court cases on record: 25 filed by Medreich, 13 filed against it, 15 where it is another party. 10 cases are pending and 43 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 38 | 8 | 6 |
| District courts | 15 | 5 | 4 |
Cases on record (5 of 53)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Allahabad High Court | Court case (A227) | Filed by the company against Jubilant Generics Limited | Disposed |
| Allahabad High Court | Court case (CRLP) | Company is another party | Pending |
| Allahabad High Court | Court case (CRLP) | Filed by the company against State of U.P. and 3 others | Pending |
| High Court of Karnataka | Writ petition | Company is another party | Pending |
| District court, BENGALURU RURAL, Karnataka | Civil suit | Company is another party | Pending |
Full case history
All 53 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Medreich Limited
Medreich Limited has 3 MSME Form 1 returns on record between 2019 and 2024, listing 16 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Parekhplast India Limited | •••• | •••• | •••• |
| Labsupplies India Private Limited | •••• | •••• | •••• |
| Ami Polymer Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Electrolab (India) Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Medreich Limited
Medreich operates one associated brand: Medreich. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical contract manufacturing and development services are provided. | medreich.com |
Employees and EPFO Compliance at Medreich Limited
Medreich Limited has a workforce of 1,833 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Medreich Limited
Medreich has 2 subsidiary companies and 1 joint venture. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Genovo Development Services Limited | U24230KA2008PLC046164 | Locked |
| Medreich Lifecare Limited | U24230KA2008PLC062782 | Locked |
Showing major subsidiaries. Total: 2.
Name History of Medreich Limited
Medreich has undergone 4 name changes throughout its history. The current legal name is Medreich Limited.
| Company Name | Status |
|---|---|
| Medreich Limited | Current |
| Sterilab Private Limited | Previous |
| Medreich Sterilab Private Limited | Previous |
| The Mukund Insurance Co. Limited | Previous |
| The Prakash Insurance Co. Limited | Previous |
Recent Activity on Medreich Limited
Medreich Limited has 47 board changes on record since 2008: 8 appointments and 39 cessations. The latest: Yasuhiro Nakagiri was appointed as Additional Director on 09 May 2024.
66 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Medreich Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medreich Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medreich Limited
Medreich has 6 GST registrations: 2 active and 4 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCM1458Q1ZW | Karnataka | Active | 01 Jul 2017 |
| 36AABCM1458Q1Z1 | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medreich Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medreich Limited
Medreich is an active public limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 August 1973 (53+ years old) and is registered under CIN U24232KA1973PLC002383.
Medreich reported revenue of ₹1,737.11 Cr for FY 2024 (up 8% YoY).
Medreich has 6 current directors:
- Pankaj Garg - Managing Director
- Tsutomu Yamada - Director
- Yasuhiro Nakagiri - Additional Director
- Misa Hirose - Director
- Kenshi Murase - Director
- Ryoji Kikuchi - Director
Medreich reported a net profit of ₹226.55 Cr (net margin 13%) and EBITDA of ₹294.66 Cr (EBITDA margin 17%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medreich is 9% over three years and 9% over five years. In the latest year (FY 2024) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medreich is 29AABCM1458Q1ZW, registered in Karnataka. The company has 6 GST registrations in all, of which 2 are active and 4 are cancelled or inactive. Other active GSTINs include 36AABCM1458Q1Z1 (Telangana).
The CIN (Corporate Identification Number) of Medreich is U24232KA1973PLC002383. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medreich has 53 court cases on record: 25 filed by the company and 13 filed against it. 10 are pending. Most are in the high courts.
Medreich was incorporated on 16 August 1973, making it 53+ years old. It is registered with the Registrar of Companies, Bangalore.
Medreich has 1 deal on record (1 secondary share transfer); the latest was in June 2015.
Yasuhiro Nakagiri was appointed as Additional Director on 09 May 2024. Tsutomu Yamada ceased to be Additional Director on 28 Sep 2023. Tsutomu Yamada was appointed as Director on 31 Jul 2023. Medreich has 47 board changes on record in total.